Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cornerstone Health Care, PA
With
Allergan
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Open-angle glaucoma or ocular Hypertension
Currently treated with Latanoprost for min of 6 weeks
Male or Female 18 yrs and older
Best Corrected Visual Acuity 20/100 or better in both eyes
Pachymetry \>470 and \< 640
Women of childbearing potential must have a negative urine pregnancy test at the screening/baseline visit
Patient willing and capable of providing informed consent
You may not be if
C/D \> 0.8
Visual field loss, which in the opinion of the investigator is functionally significant
Current use of ocular steroids
Concurrent significant active ocular disease History (within 3 months prior to Screening) of ocular laser, intraocular, filtering or refractive surgery or planned ocular surgery of any kind during study participation
Change within prior 30 days or anticipated change in any systemic medication that is known to affect IOP
Uncontrolled systemic disease
Significant ocular hyperemia at baseline
Prior glaucoma procedure within 3 months
Females who are pregnant, nursing, or planning a pregnancy or who are of childbearing potential and not using a reliable method of contraception
Known allergy or sensitivity to any study medication
Asthma or any other known medical condition that the investigator feels would put patient at increased risk from any of the study medications
Current enrollment in an investigational drug or device study or participation in such a study within 30 days prior to Screening
Clareo Health | Comparison of Combigan Two Times Daily (BID) Versus Simbrinza Three Times Daily (TID)
